Cervical Cancer and its Vaccine Trends in Low- and Middle-Income Countries: A highlight

Authors

  • Fatima Yasin Mayo Hospital
  • Qasim Mehmood King Edward Medical University
  • Sidra Imtiaz Karachi Medical and Dental College
  • Irfan Ullah Gandhara University
  • Sufyan Razak Dow University of Health Sciences

DOI:

https://doi.org/10.56101/rimj.v3i1.66

Abstract

N/A

Author Biographies

Fatima Yasin, Mayo Hospital

Medicine, Mayo Hospital, Lahore, Pakistan.

Qasim Mehmood, King Edward Medical University

King Edward Medical University, Lahore, Pakistan.

Sidra Imtiaz, Karachi Medical and Dental College

Karachi Medical and Dental College, Karachi, Pakistan.

Irfan Ullah, Gandhara University

Kabir Medical College, Gandhara University, Peshawar, Pakistan.

Sufyan Razak, Dow University of Health Sciences

Dow University of Health Sciences, Civil Hospital Karachi, Karachi, Pakistan.

References

Chen YF, Shen MR. The Important Role of Ion Transport System in Cervical Cancer. International journal of molecular sciences. 2022 Jan;23(1):333.

Cervical cancer: Causes, symptoms, diagnosis, treatment, & outlook [Internet]. WebMD; [cited 2022 Aug 28]. Available from: https://www.webmd.com/cancer/cervical-cancer/cervical-cancer

Johnson CA, James D, Marzan A, Armaos M. Cervical cancer: an overview of pathophysiology and management. InSeminars in oncology nursing 2019 Apr 1 (Vol. 35, No. 2, pp. 166-174). WB Saunders.

Colzani E, Johansen K, Johnson H, Celentano LP. Human papillomavirus vaccination in the European Union/European Economic Area and globally: A moral dilemma. Eurosurveillance. 2021 Dec 16;26(50):2001659.

Buskwofie A, David-West G, Clare CA. A review of cervical cancer: incidence and disparities. Journal of the National Medical Association. 2020 Apr 1;112(2):229-32.

Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, Martin D, Simms KT, Bénard É, Boily MC, Sy S. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. The Lancet. 2020 Feb 22;395(10224):575-90.

Toh ZQ, Licciardi PV, Russell FM, Garland SM, Batmunkh T, Mulholland EK. Cervical cancer prevention through HPV vaccination in low-and middle-income countries in Asia. Asian Pacific Journal of Cancer Prevention: APJCP. 2017;18(9):2339.

Ladner J, Besson MH, Audureau E, Rodrigues M, Saba J. Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014. BMC health services research. 2016 Dec;16(1):1-0.

Ver AT, Notarte KI, Velasco JV, Buac KM, Nazareno III J, Lozañes JA, Antonio D, Bacorro W. A systematic review of the barriers to implementing human papillomavirus vaccination programs in low‐and middle‐income countries in the Asia‐Pacific. Asia‐Pacific Journal of Clinical Oncology. 2021 Dec;17(6):530-45.

Shinkafi-Bagudu Z. Global partnerships for HPV vaccine must look beyond national income. JCO Global Oncology. 2020;6.

Published

2023-05-30

How to Cite

Yasin, F., Mehmood, Q., Imtiaz, S. ., Ullah, I., & Razak, S. (2023). Cervical Cancer and its Vaccine Trends in Low- and Middle-Income Countries: A highlight. Razi International Medical Journal, 3(1), 6–8. https://doi.org/10.56101/rimj.v3i1.66

Issue

Section

COMMENTARY(S)